Company Filing History:
1 out of 149 
1 out of 832,912 Years Active: 2013-2017
Title: Manish Raisinghani: Innovator in Dopamine Reuptake Inhibitors
Introduction
Manish Raisinghani is a notable inventor based in Jamesburg, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of dopamine reuptake inhibitors. With a total of 2 patents, his work focuses on innovative solutions for treating dopamine-related disorders.
Latest Patents
Raisinghani's latest patents include "Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders." These patents detail derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins. This innovative approach is useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
Career Highlights
Throughout his career, Raisinghani has worked with various organizations, including Caliper Life Sciences, Inc. His experience in the industry has allowed him to develop groundbreaking solutions that address critical health issues related to dopamine regulation.
Collaborations
Some of his notable coworkers include Hao Chen and Ming Liu. Their collaborative efforts have contributed to the advancement of research in the field of dopamine reuptake inhibitors.
Conclusion
Manish Raisinghani's innovative work in the development of dopamine reuptake inhibitors showcases his commitment to improving treatments for dopamine-related disorders. His contributions are paving the way for future advancements in pharmacological research.